saascode
My App
AnnexedliteSelf-serve EU GMP Annex 11 and 21 CFR Part 11 gap-assessment software that auto-discovers a mid-market biotech's GxP system inventory, runs a conformance check against the revised Annex 11, and produces an EMA-inspector-ready remediation dossier.
0/5000%
biotech, life sciences & pharma·run 055 · May 2026

Annexedlite

Self-serve EU GMP Annex 11 and 21 CFR Part 11 gap-assessment software that auto-discovers a mid-market biotech's GxP system inventory, runs a conformance check against the revised Annex 11, and produces an EMA-inspector-ready remediation dossier.

Genesis score6.90/10
Make Annexedlite real.0/500
500 more votes and Annexedlite is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The opportunity
$25-80KConsultant cost displaced
Mid-2026Annex 11 final
EmptyMid-market tier today
The case

A 100-1000 FTE biotech or CDMO knows the revised Annex 11 is coming and has no idea where its LIMS, MES, QMS, and ERP fall short of it. Today the only way to find out is to write a $25-80K check to a GxP consultant, wait weeks for a manual audit, and receive a static report that is stale the moment a system changes or the regulation revises again. The quality lead owns inspection readiness for the whole estate but has neither the enterprise validation suite the big players sell nor the budget to keep buying audits.

Who pays — and why

The quality or compliance lead at a 100-1000 FTE biotech or CDMO who personally owns inspection readiness and already spends on $25-80K GxP consulting engagements.

Market signal$499-$5K/mo/mo - the explicitly empty mid-market band between free tooling and enterprise; a market reference, set your own
What it unlocks
A self-serve foothold in the mid-market GxP compliance tier that the Veeva/CRO duopoly prices out
A per-customer system-inventory and remediation-history corpus that compounds into switching cost
A regulation-diff rule corpus that re-runs every customer's assessment automatically when EMA publishes
A procurement-mandatory dossier format once a single customer passes an inspection on it
How Genesis scored it
6.90across seven criteria
tension 7temporal 9blindspot 7buyer 7leverage 6convergence 5why-not 8
9
Temporal window

A confirmed, dated, named trigger: the Annex 11 19-page revision, final publication targeted for mid-2026, transition into 2027 - inside 24 months.

8
Why nobody did it

The artifact to check against, the revised Annex 11, did not exist before the 2026 draft - a clean 'the regulation just enabled it' answer.

5
Convergence

Moderate: one cross-reference mention, two inbound connections, six connections that are mostly run-021/051 kin.

Why it scored well

A dated, named regulatory trigger inside 24 months sitting on top of an explicitly empty mid-market pricing band - two confirmed signals and a clean 'the regulation just enabled it' answer, since the artifact to check against (the revised Annex 11) did not exist before the 2026 draft.

What's holding it back

Convergence is moderate rather than exceptional, asymmetric leverage is dragged down because GxP auto-discovery and conformance confidence may pull toward expert review (and only one of four candidate APIs is verified), and the deeper risk is that GxP buyers may distrust a self-serve assessment for inspection-critical decisions.

Signals detected3 sources crossed
SignalCertivo / Eupry regulatory guides

SignalIncumbent pricing analysis

SignalCompetitor scan

Connected ideas· 4 in the web

Genesis doesn't invent in isolation — Annexedlite shares architecture with, or powers, these ideas.

Direction briefannexedlite.md
annexedlite.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.

Annexedlite — Genesis · saascode